GSTM1 null allele is a risk factor for gastric cancer development in Asians

Cytokine

Volumn 55, Issue 1, 2011, Pages 122-125

  Qiu, Li Xin ^a,b   Wang, Ke ^c   Lv, Fang Fang ^a,b   Chen, Zhi Yu ^a,b   Liu, Xin ^a,b   Zheng, Chun Lei ^a,b   Li, Wen Hua ^a,b   Zhu, Xiao Dong ^a,b   Guo, Wei Jian ^a,b   Li, Jin ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer susceptibility; Genetic polymorphism; GSTM1; Meta analysis

Indexed keywords

GLUTATHIONE TRANSFERASE M1;

ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GSTM1 GENE; HETEROZYGOSITY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; NULL ALLELE; ONCOGENE; POPULATION BASED CASE CONTROL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOGENESIS; SYSTEMATIC REVIEW;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; ODDS RATIO; PRECANCEROUS CONDITIONS; PUBLICATION BIAS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 79956343572     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.03.004     Document Type: Article

References (56)

1. Ahmedin J.D., Freddie B., Melissa M. Global cancer statistics 2008. CA Cancer J Clin 2011, 10.3322/caac.2010.
2. Lichtenstein P., Holm N.V., Verkasalo P.K. Environmental and heritable factors in the causation of cancer. N Engl J Med 2000, 343:78-85.
3. Yager J.D., Davidson N.E. Estrogen carcinogenesis in gastric Cancer. N Engl J Med 2006, 354:270-282.
4. Palli D., Polidoro S., D'Errico M., Saieva C., Guarrera S., Calcagnile A.S. Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer. Mutagenesis 2010, 25:569-575.
5. Yadav D.S., Devi T.R., Ihsan R., Mishra A.K., Kaushal M., Chauhan P.S. Polymorphisms of glutathione-S-transferase genes and the risk of aerodigestive tract cancers in the Northeast Indian population. Genet Test Mol Biomarkers 2010, 14:715-723.
6. Luo Y.P., Chen H.C., Khan M.A., Chen F.Z., Wan X.X., Tan B. Genetic polymorphisms of metabolic enzymes-CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibility. Tumour Biol 2011, 32:215-222.
7. Nguyen T.V., Janssen M.J., van Oijen M.G. Genetic polymorphisms in GSTA1, GSTP1, GSTT1, and GSTM1 and gastric cancer risk in a Vietnamese population. Oncol Res 2010, 18:349-355.
8. Masoudi M., Saadat I., Omidvari S., Saadat M. Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Mol Biol Rep 2009, 36:781-784.
9. Al-Moundhri M.S., Alkindy M., Al-Nabhani M. Combined polymorphism analysis of glutathione S-transferase M1/G1 and interleukin-1B (IL-1B)/interleukin 1-receptor antagonist (IL-1RN) and gastric cancer risk in an Omani Arab Population. J Clin Gastroenterol 2009, 43:152-156.
10. Deakin M., Elder J., Hendrickse C. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 1996, 17:881-884.
11. Katoh T., Nagata N., Kuroda Y. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 1996, 17:1855-1859.
12. Martins G., Alves M., Dias J. Glutathione S-transferase μ polymorphism and gastric cancer in the Portuguese population. Biomarkers 1998, 3:441-447.
13. Cai L., Yu S., Chen J. Relationship between glutathione S-transferase M1, T1 genotype and susceptibility to gastric cancer. Zhonghua Yu Fang Yi Xue Za Zhi 1999, 33:331-333.
14. Oda Y., Kobayashi M., Ooi A., Muroishi Y., Nakanishi I. Genotypes of glutathione S-transferase M1 and N-acetyltransferase 2 in Japanese patients with gastric cancer. Gastric cancer 1999, 2:158-164.
15. Setiawan V.W., Zhang Z.F., Yu G.P., Li Y.L., Lu M.L., Tsai C.J. GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev 2000, 9:73-80.
16. Lan Q., Chow W.H., Lissowska J., Hein D.W., Buetow K., Engel L.S. Glutathione S-transferase genotypes and stomach cancer in a population-based case-control study in Warsaw, Poland. Pharmacogenetics 2001, 11:655-661.
17. Gao C.M., Takezaki T., Wu J.Z., Li Z.Y., Liu Y.T., Li S.P. Glutathione-S-transferases M1 (GSTM1) and GSTT1 genotype, smoking, consumption of alcohol and tea and risk of esophageal and stomach cancers: a case-control study of a high-incidence area in Jiangsu Province, China. Cancer Lett 2002, 188:95-102.
18. Wu M.S., Chen C.J., Lin M.T., Wang H.P., Shun C.T., Sheu J.C. Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan. Int J Colorectal Dis 2002, 17:338-343.
19. Choi S.C., Yun K.J., Kim T.H., Kim H.J., Park S.G., Oh G.J. Prognostic potential of glutathione S-transferase M1 and T1 null genotypes for gastric cancer progression. Cancer Lett 2003, 195:169-175.
20. Colombo J., Rossit A.R., Caetano A., Borim A.A., Wornrath D., Silva A.E. GSTT1, GSTM1 and CYP2E1 genetic polymorphisms in gastric cancer and chronic gastritis in a Brazilian population. World J Gastroenterol 2004, 10:1240-1245.
21. Roth M.J., Abnet C.C., Johnson L.L., Mark S.D., Dong Z.W., Taylor P.R. Polymorphic variation of Cyp1A1 is associated with the risk of gastric cardia cancer: a prospective case-cohort study of cytochrome P-450 1A1 and GST enzymes. Cancer Causes Control 2004, 15:1077-1083.
22. Suzuki S., Muroishi Y., Nakanishi I., Oda Y. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer. J Gastroenterol 2004, 39:220-230.
23. Torres M.M., Acosta C.P., Sicard D.M., de Restrepo H.G. Genetic susceptibility and risk of gastric cancer in a human population of Cauca, Colombia. Biomedica 2004, 24:153-162.
24. Lai K.C., Chen W.C., Tsai F.J., Li S.Y., Chou M.C., Jeng L.B. Glutathione S-transferase M1 gene null genotype and gastric cancer risk in Taiwan. Hepatogastroenterology 2005, 52:1916-1919.
25. Li H., Chen X.L., Li H.Q. Polymorphism of CYPIA1 and GSTM1 genes associated with susceptibility of gastric cancer in Shandong Province of China. World J Gastroenterol 2005, 11:5757-5762.
26. Mu L.N., Lu Q.Y., Yu S.Z., Jiang Q.W., Cao W., You N.C. Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer 2005, 116:972-983.
27. Shen J., Wang R.T., Xu Y.C., Wang L.W., Wang X.R. Interaction models of CYP1A1, GSTM1 polymorphisms and tobacco smoking in intestinal gastric cancer. World J Gastroenterol 2005, 11:6056-6060.
28. Tamer L., Ates N.A., Ates C., Ercan B., Elipek T., Yildirim H. Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk. Cell Biochem Funct 2005, 23:267-272.
29. Nan H.M., Park J.W., Song Y.J., Yun H.Y., Park J.S., Hyun T. Kimchi and soybean pastes are risk factors of gastric cancer. World J Gastroenterol 2005, 11:3175-3181.
30. Palli D., Saieva C., Gemma S., Masala G., Gomez-Miguel M.J., Luzzi I. GSTT1 and GSTM1 gene polymorphisms and gastric cancer in a high-risk italian population. Int J Cancer 2005, 115:284-289.
31. Agudo A., Sala N., Pera G., Capella G., Berenguer A., Garcia N. No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2006, 15:1043-1045.
32. Hong S.H., Kim J.W., Kim H.G., Park I.K., Ryoo J.W., Lee C.H. Glutathione S-transferases (GSTM1, GSTT1 and GSTP1) and N-acetyltransferase 2 polymorphisms and the risk of gastric cancer. J Prev Med Public Health 2006, 39:135-140.
33. Lee K., Caceres D., Varela N., Csendes D.A., Rios R.H., Quinones S.L. Allelic variants of cytochrome P4501A1 (CYP1A1), glutathione S transferase M1 (GSTM1) polymorphisms and their association with smoking and alcohol consumption as gastric cancer susceptibility biomarkers. Rev Med Chil 2006, 134:1107-1115.
34. Martinez C., Martin F., Fernandez J.M., Garcia-Martin E., Sastre J., Diaz-Rubio M. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics 2006, 7:711-718.
35. Boccia S., Sayed-Tabatabaei F.A., Persiani R., Gianfagna F., Rausei S., Arzani D. Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population. BMC Cancer 2007, 7:206-210.
36. Ruzzo A., Canestrari E., Maltese P., Pizzagalli F., Graziano F., Santini D. Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer. Clin Chem Lab Med 2007, 45:822-828.
37. Wideroff L., Vaughan T.L., Farin F.M., Gammon M.D., Risch H., Stanford J.L. GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas. Cancer Detect Prev 2007, 31:233-236.
38. Harada S., Misawa S., Nakamura T., Tanaka N., Ueno E., Nozoe M. Detection of GST1 gene deletion by the polymerase chain reaction and its possible correlation with stomach cancer in japanese. Hum Genet 1992, 90:62-64.
39. Scibior D., Skrzycki M., Podsiad M., Czeczot H. Glutathione level and glutathione-dependent enzyme activities in blood serum of patients with gastrointestinal tract tumors. Clin Biochem 2008, 41:852-858.
40. Conde A.R., Martins G., Saraiva C., Rueff J., Monteiro C. Association of p53 genomic instability with the glutathione S-transferase null genotype in gastric cancer in the Portuguese population. Mol Pathol 1999, 52:131-134.
41. Cai L., Yu S.Z., Zhang Z.F. Glutathione S-transferases M1, T1 genotypes and the risk of gastric cancer: a case-control study. World J Gastroenterol 2001, 7:506-509.
42. Gonzalez C.A., Sala N., Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer 2002, 100:249-260.
43. Norum P.L., Kaerlev L., Stubbe T.P., Olsen J., Eriksson M., Guenel P. Glutathione S-transferase genotype and p53 mutations in adenocarcinoma of the small intestine. Scand J Gastroenterol 2003, 38:845-849.
44. Chen S.Y., Liu T.Y., Shun C.T., Wu M.S., Lu T.H., Lin J.T. Modification effects of GSTM1, GSTT1 and CYP2E1 polymorphisms on associations between raw salted food and incomplete intestinal metaplasia in a high-risk area of stomach cancer. Int J Cancer 2004, 108:606-612.
45. Wu M.S., Shun C.T., Huang S.P., Cheng A.L., Chen L.T., Lin J.T. Effect of interleukin-1beta and glutathione S-transferase genotypes on the development of gastric mucosa-associated lymphoid tissue lymphoma. Haematologica 2004, 89:1015-1017.
46. Izzotti A., De Flora S., Cartiglia C., Are B.M., Longobardi M., Camoirano A. Interplay between Helicobacter pylori and host gene polymorphisms in inducing oxidative DNA damage in the gastric mucosa. Carcinogenesis 2007, 28:892-898.
47. La Torre G., Boccia S., Ricciardi G. Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett 2005, 217:53-60.
48. Cochran W.G. The combination of estimates from different experiments. Biometrics 1954, 10:101-129.
49. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
50. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
51. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 1999, 8:15-17.
52. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
53. Taylor S.J., Tweedie R.I. Practical estimates of the effect of publication bias in meta-analysis. Australas Epidemiol 1998, 5:14-17.
54. Salinas A.E., Wong M.G. Glutathione S-transferases - a review. Curr Med Chem 1999, 6:279-309.
55. Hirschhorn J.N., Lohmueller K., Byrne E. A comprehensive review of genetic association studies. Genet Med 2002, 4:45-61.
56. Wacholder S., Chanock S., Garcia-Closas M. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004, 96:434-442.